Precautionary practices of respiratory therapists and other health-care practitioners who administer aerosolized medications

Respiratory Care

Volumn 60, Issue 10, 2015, Pages 1410-1417

  Tsai, Rebecca J ^a   Boiano, James M ^a   Steege, Andrea L ^a   Sweeney, Marie H ^a  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

Aerosolized medications; Antibiotics; Exposure controls; Pentamidine; Respiratory therapists; Web based survey

Indexed keywords

AMIKACIN; COLISTIN; PENTAMIDINE; RIBAVIRIN; TOBRAMYCIN; AEROSOL; ANTIINFECTIVE AGENT;

ADULT; AEROSOL; AIR FILTER; ARTICLE; COWORKER; DRUG DELIVERY DEVICE; DRUG EXPOSURE; DRUG THERAPY; EMPLOYER; ENVIRONMENTAL MONITORING; FEMALE; HEALTH CARE PERSONNEL; HEALTH CARE PRACTICE; HUMAN; MALE; NURSE; OCCUPATIONAL HEALTH SERVICE; PROFESSIONAL PRACTICE; PROFESSIONAL STANDARD; RESPIRATORY THERAPIST; SAFETY; SURGICAL GLOVE; TRAINING; EDUCATION; MIDDLE AGED; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HEALTH; PREVENTION AND CONTROL; PROCEDURES; PROTOCOL COMPLIANCE; QUESTIONNAIRE; RESPIRATORY CARE; STANDARDS; STATISTICS AND NUMERICAL DATA; UNITED STATES;

ADULT; AEROSOLS; AMIKACIN; ANTI-INFECTIVE AGENTS; COLISTIN; FEMALE; GUIDELINE ADHERENCE; HEALTH PERSONNEL; HUMANS; MALE; MIDDLE AGED; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH (U.S.); OCCUPATIONAL EXPOSURE; OCCUPATIONAL HEALTH; PENTAMIDINE; RESPIRATORY THERAPY; SURVEYS AND QUESTIONNAIRES; TOBRAMYCIN; UNITED STATES;

EID: 84944725235     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: 10.4187/respcare.03817     Document Type: Article

References (29)

1. Jost M, Ahrens R, Beaudouin L, Eickmann U, Falcy M, Rüegger M. Occupational risk prevention in aerosol therapy (pentamidine, ribavirin). http://www.issa.int/details?uuid_c3ca6ed0-8658-4859-884fcbdd4c27fb65. Accessed February 17, 2015.
2. O’Hara CM, Anton WR, Gormley FX, Brazell C. Administration of aerosol pentamidine: a program design. J Assoc Nurses AIDS Care 1994;5(2):41-48.
3. Wood GC, Boucher BA. Aerosolized antimicrobial therapy in acutely ill patients. Pharmacotherapy 2000;20(2):166-181.
4. O’Riordan TG, Smaldone GC. Exposure of health care workers to aerosolized pentamidine. Chest 1992;101(6):1494-1499.
5. Gorman T, Dropkin J, Kamen J, Nimbalkar S, Zuckerman N, Lowe T, et al. Controlling health hazards to hospital workers. New Solut 2013;23(Suppl):1-167.
6. Bothra M, Lodha R, Kabra SK. Tobramycin for the treatment of bacterial pneumonia in children. Expert Opin Pharmacother 2012; 13(4):565-571.
7. Montgomery AB, Corkery KJ, Brunette ER, Leoung GS, Waskin H, Debs RJ. Occupational exposure to aerosolized pentamidine. Chest 1990;98(2):386-388.
8. Antoniu SA, Cojocaru I. Inhaled colistin for lower respiratory tract infections. Expert Opin Drug Deliv 2012;9(3):333-342.
9. Neu HC. Tobramycin: an overview. J Infect Dis 1976;134(Suppl): S3-19.
10. Lane AZ, Wright GE, Blair DC. Ototoxicity and nephrotoxicity of amikacin: an overview of phase II and phase III experience in the United States. Am J Med 1977;62(6):911-918.
11. Green S, Nathwani D, Christie P, Kennedy D. Aerosolised pentamidine. Lancet 1989;2(8674):1284-1285.
12. Stanbury M, Gatti E, Sokolowski JW. Reactive airways dysfunction syndrome in a nurse exposed to pentamidine. J Occup Environ Med 1996;38(4):330-331.
13. Harstad TW, Little BB, Bawdon RE, Knoll K, Roe D, Gilstrap LC 3rd. Embryofetal effects of pentamidine isethionate administered to pregnant Sprague-Dawley rats. Am J Obstet Gynecol 1990;163(3): 912-916.
14. Munzenberger PJ, Walker PC. Protecting hospital employees and visitors from aerosolized ribavirin. Am J Hosp Pharm 1994;51(6): 823-826.
15. Occupational Safety and Health Administration. Controlling occupational exposure to hazardous drugs. In: OSHA technical manual (OTM), TED1-015A, Section VI, Chapter 2. 1999.
16. Smaldone GC, Vinciguerra C, Marchese J. Detection of inhaled pentamidine in health care workers. N Engl J Med 1991;325(12): 891-892.
17. Shults RA, Baron S, Decker J, Deitchman SD, Connor JD. Health care worker exposure to aerosolized ribavirin: biological and air monitoring. J Occup Environ Med 1996;38(3):257-263.
18. Dimich-Ward H, Wymer ML, Chan-Yeung M. Respiratory health survey of respiratory therapists. Chest 2004;126(4):1048-1053.
19. Kern DG, Frumkin H. Asthma in respiratory therapists. Ann Intern Med 1989;110(10):767-773.
20. Christiani DC, Kern DG. Asthma risk and occupation as a respiratory therapist. Am Rev Respir Dis 1993;148(3):671-674.
21. Centers for Disease Control and Prevention. Preventing occupational exposures to antineoplastic and other hazardous drugs in health care setting. NIOSH Alert 2004, DHHS NIOSH Publication 2004-165.
22. Manuele FA. Risk assessment and hierarchy of control. Prof Safety 2005;50:33-39.
23. Gardenhire DS, Ari A, Hess D, Myers TR. A guide to aerosol delivery devices for respiratory therapists, 3rd edition. http://www.aarc.org//app/uploads/2014/08/aerosol_guide_rt.pdf. Accessed February 17, 2015.
24. American Society of Health-System Pharmacists. ASHP guidelines on handling hazardous drugs. Am J Health Syst Pharm 2006;63: 1172-1193.
25. McDiarmid MA, Fujikawa J, Schaefer J, Weinmann G, Chaisson RE, Hudson CA. Health effects and exposure assessment of aerosolized pentamidine handlers. Chest 1993;104(2):382-385.
26. Steege AL, Boiano JM, Sweeney MH. NIOSH Health and Safety Practices Survey of Healthcare Workers: training and awareness of employer safety procedures. Am J Ind Med 2014;57(6):640-652.
27. Centers for Disease Control and Prevention. Distinguishing public health research and public health nonresearch. http://www.cdc.gov/od/science/integrity/docs/cdc-policy-distinguishing-public-healthresearch- nonresearch.pdf. Accessed February 17, 2015.
28. Occupational Safety and Health Administration. Hazard communication standard 29 CFR 19010.1200. https://www.osha.gov/pls/oshaweb/owadisp.show_document?p_table_STANDARDS&p_id_10099. Accessed February 17, 2015.
29. Balmes JR, Estacio PL, Quinlan P, Kelly T, Corkery K, Blanc P. Respiratory effects of occupational exposure to aerosolized pentamidine. J Occup Environ Med 1995;37(2):145-150.